Contact Person
David Munis Zepernick

Head of Business Development and Public Affairs

Phone: (M) +45 2498 1668


Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

25 Nov

Stronger together – opinion piece by MVA CEO, Petter Hartman and Senior Manager, Sarah Lidé in Pharma Industry

“Stronger together – harnessing the power of collaboration across borders” is the full title of the opinion piece recently published online in the Swedish pharma business journal, Pharma Industry. The piece, which emphasizes and highlights the potential for strengthening  cross

24 Nov

Medicon Valley Alliance member, Roche Pharmaceuticals, awarded “Best place to work” in Denmark 2019

Medicon Valley Alliance would like to congratulate, Roche Pharmaceuticals, with the prestigious “Best Place to work-award” awarded by the organisation, Great Place to Work last week.  Roche Pharmaceuticals, which was the only life science company among the winners, was awarded

04 Nov

The Medicon Valley region’s life science industry is still expanding and the life science sector has grown more important for both the Danish and Swedish national economies

These are some of the conclusion in the 2019 edition of the “State of Medicon Valley analysis” published today and presented at the Medicon Valley Alliance Annual Meeting this afternoon. The analysis, which can be downloaded free of charge here,

04 Nov

“Medicon Valley is an important part of Swedish life science” Column in today´s edition of Swedish daily Kvällsposten

  The upcoming national Swedish life science strategy must take the Medicon Valley region´s potential for growth and collaboration into account, according to MVA CEO, Petter Hartman, and chairman of regional development, Region Skåne, Anna Jähnke (M). Read full column

31 Oct

Don´t miss the recently published Copenhagen Post business column by MVA chairman, Søren Bregenholt

In the recently published edition of Copenhagen Post Medicon Valley Alliance chairman, Søren Bregenholt, highlights the unique window of opportunity to strengthen the coordination and collaboration between the Danish and Swedish national life science strategies. (See page 13 here) The

25 Oct

Call for national funding for cross-border life science initiatives

The need for national funding for cross-border life science initiatives was among the topics discussed at last week´s high-level seminar in the Swedish Parliament, Riksdagen, organized by Medicon Valley Alliance and Region Skåne, and hosted by MP´s Rikard Larsson (S)

15 Oct

Copenhagen Bio Science Park (COBIS) ranked among top 20 European Biotech Incubators

In the recently published Labiotech-ranking of European Biotech Incubators, COBIS, makes the list as the only Danish and Medicon Valley based incubator. There are, however, two Swedish incubators on the list, which also includes AstraZeneca BioVentureHub in Mölndal and Umeå

14 Oct

New State of the region analysis published by Øresundsinstituttet

The recently published State of the Øresund region analysis covers a broad range of  highly relevant issues including infra-structure and traffic, cultural collaboration and health care and life science. As part of the latter, MVA CEO, Petter Hartman is interviewed

09 Oct

Lund Faculty of Medicine interviews MVA CEO, Petter Hartman, about the value of life science networks

“Sweden has strong innovation environments and a tradition of commercialisation. Denmark has large investors in pharmaceuticals as well as capital-rich private foundations. This creates exciting dynamics and makes us more competitive”, says MVA CEO Petter Hartman in a recently published